GS JT (Votrient pazopanib 200 mg)
Generic Name: pazopanib
Pill imprint GS JT has been identified as Votrient pazopanib 200 mg.
Votrient is used in the treatment of soft tissue sarcoma; renal cell carcinoma and belongs to the drug class VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Votrient pazopanib 200 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- pazopanib 200 mg
- 14.00 mm
- Prescription only
sodium starch glycolate type A potato
polyethylene glycol 400
More about Votrient (pazopanib)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.